New York, United States, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Onychomycosis is a fungal condition that affects the fingernails and toenails and can be painful, ugly, and persistent. Several types of ...

Valeant announced that the FDA has approved Jublia (efinaconazole 10%) topical solution for the treatment of onychomycosis of the toenails (distal lateral subungual onychomycosis [DLSO]). Jublia is ...

New York, March 23, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Onychomycosis Market Size, Share & Industry Trends Analysis Report By Type, By Treatment, By ...

Accounting for approximately 12% of the entire fungal infection treatments space, onychomycosis treatment has been witnessing a high prevalence-low awareness scenario over the years. However, ...

Westford, USA, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Onychomycosis Market size was valued at USD 3.5 billion in 2023 to USD 5.05 billion by 2031, at a CAGR of 4.7% during the forecast period (2024-2031).

The Onychomycosis market growth is driven by factors like increase in the prevalence of Onychomycosis, investments in research and development, entry of emerging therapies during the study period 2020 ...

TOPICA Pharmaceuticals, Inc., has announced positive results from its Phase 1/2a trial evaluating the safety, tolerability and pharmacokinetics of a 10% solution of luliconazole after maximal use ...

March 17, 2010 (Miami Beach, Florida) — A new topical emulsion (currently known as NB-002; NanoBio Corporation) was effective in treating mild distal subungual onychomycosis (DSO), a chronic ...

LONDON--(BUSINESS WIRE)--Technavio has announced their latest drug pipeline analysis report on onychomycosis. The report includes a detailed analysis of the pipeline molecules under investigation ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio A 4-year-old boy presents with concern ...

The US Food and Drug Administration (FDA) has approved efinaconazole 10% topical solution (Jublia, Valeant Pharmaceuticals) for the treatment of onychomycosis of the toenail, the company announced ...